17326-22-6

Basic information

• Product Name: 2-chloro-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
• Synonyms: 2-chloro-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
• CAS NO: 17326-22-6
• Molecular Formula: C9H7ClN2O
• Molecular Weight: 194.61768
• Mol File: 17326-22-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 295.2°C at 760 mmHg
• Flash Point: 132.3°C
• Appearance: /
• Density: 1.37g/cm³
• Vapor Pressure: 0.00155mmHg at 25°C
• Refractive Index: 1.642
• CAS DataBase Reference: 2-chloro-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one(17326-22-6)
• EPA Substance Registry System: 2-chloro-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one(17326-22-6)

Safety Data

• Hazardous Substances Data: 17326-22-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H7ClN2O/c1-6-3-2-4-12-8(13)5-7(10)11-9(6)12/h2-5H,1H3

Upstream product

• 1603-40-3 3-methylpyridin-2-ylamine 
• 1204419-46-4 Ethyl 3-(3-methylpyridin-2-ylamino)-3-oxopropanoate 
• 17326-09-9 2-hydroxy-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 

Relevant articles and documents

PYRIDMIDONES FOR TREATMENT OF POTASSIUM CHANNEL RELATED DISEASES

The present invention relates to compounds of Formula I as described herein or a 1 pharmaceutically acceptable salt thereof, pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt thereof and methods of treating, or manufacture of a medicament to treat, a disease, disorder, or condition of the central nervous system, including bipolar disorder, depressive disorders, anxiety disorders, cognitive disorders, pain disorders, urogenital disorders, and epilepsy, among the other diseases, disorders or conditions discussed herein as mono-therapy or in combination with another active pharmaceutical ingredient.

Anti-infective compounds

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.